Coumel tachycardia in children.

IF 0.6 Q4 PEDIATRICS
Enrique Velázquez-Rodríguez, Norberto García-Hernández, Arturo Martínez-Sánchez, Carlos Alva-Espinoza, Lucelly Yáñez-Gutiérrez, Santiago Jiménez-Arteaga
{"title":"Coumel tachycardia in children.","authors":"Enrique Velázquez-Rodríguez,&nbsp;Norberto García-Hernández,&nbsp;Arturo Martínez-Sánchez,&nbsp;Carlos Alva-Espinoza,&nbsp;Lucelly Yáñez-Gutiérrez,&nbsp;Santiago Jiménez-Arteaga","doi":"10.24875/BMHIM.22000127","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Coumel tachycardia is an infrequent form of supraventricular tachycardia (SVT) that usually occurs in infants and children. It is a tachycardia mediated by an accessory pathway with retrograde slow conduction that explains the classic ECG pattern with long RP' interval and negative P waves in leads II, III, and aVF. In this study, we describe the clinical course and management of Coumel tachycardia in children.</p><p><strong>Case report: </strong>We conducted a retrospective review of five consecutive pediatric patients, mean age 11 ± 3 years (range 6 to 14). The first episode of SVT was at a mean age of 10.4 ± 4.8 years (range 2 to 14) with a mean evolution of 7.4 ± 9.4 months (range 1 to 24). Pharmacological therapy was unsuccessful despite the combination of antiarrhythmic drugs. The tachycardia was incessant with a density > 85% by 24-hour Holter monitoring; one patient developed tachycardia-induced cardiomyopathy. All children underwent successful radiofrequency catheter ablation, mean 5 ± 3 applications (range 1 to 8) with a single session and with no complications. After a mean follow-up of 24 ± 16 months, all patients were asymptomatic and recurrence-free without antiarrhythmic treatment.</p><p><strong>Conclusions: </strong>Coumel tachycardia is clinically persistent and usually refractory to antiarrhythmic treatment with substantial risk of tachycardia-mediated cardiomyopathy. Catheter ablation is effective and safe in children; thus, it should be indicated promptly and based on individual selection.</p>","PeriodicalId":9103,"journal":{"name":"Boletín médico del Hospital Infantil de México","volume":"80 Supl 1","pages":"69-76"},"PeriodicalIF":0.6000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Boletín médico del Hospital Infantil de México","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24875/BMHIM.22000127","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Coumel tachycardia is an infrequent form of supraventricular tachycardia (SVT) that usually occurs in infants and children. It is a tachycardia mediated by an accessory pathway with retrograde slow conduction that explains the classic ECG pattern with long RP' interval and negative P waves in leads II, III, and aVF. In this study, we describe the clinical course and management of Coumel tachycardia in children.

Case report: We conducted a retrospective review of five consecutive pediatric patients, mean age 11 ± 3 years (range 6 to 14). The first episode of SVT was at a mean age of 10.4 ± 4.8 years (range 2 to 14) with a mean evolution of 7.4 ± 9.4 months (range 1 to 24). Pharmacological therapy was unsuccessful despite the combination of antiarrhythmic drugs. The tachycardia was incessant with a density > 85% by 24-hour Holter monitoring; one patient developed tachycardia-induced cardiomyopathy. All children underwent successful radiofrequency catheter ablation, mean 5 ± 3 applications (range 1 to 8) with a single session and with no complications. After a mean follow-up of 24 ± 16 months, all patients were asymptomatic and recurrence-free without antiarrhythmic treatment.

Conclusions: Coumel tachycardia is clinically persistent and usually refractory to antiarrhythmic treatment with substantial risk of tachycardia-mediated cardiomyopathy. Catheter ablation is effective and safe in children; thus, it should be indicated promptly and based on individual selection.

儿童库梅尔性心动过速。
背景:Coumel心动过速是一种少见的室上性心动过速(SVT),通常发生在婴儿和儿童中。这是一种由伴逆行慢传导的副通路介导的心动过速,解释了II、III和aVF导联RP'间隔长和负P波的典型心电图模式。在这项研究中,我们描述了儿童Coumel心动过速的临床过程和处理。病例报告:我们对连续5例儿童患者进行了回顾性研究,平均年龄11±3岁(范围6至14岁)。首次SVT发作的平均年龄为10.4±4.8岁(2 ~ 14岁),平均病程为7.4±9.4个月(1 ~ 24个月)。药物治疗不成功,尽管联合抗心律失常药物。24小时动态心电图监测心动过速不间断,密度> 85%;1例患者出现心动过速性心肌病。所有患儿均成功进行了射频导管消融,平均5±3次(范围1 ~ 8),单次治疗,无并发症。平均随访24±16个月,无症状复发,未接受抗心律失常治疗。结论:Coumel心动过速在临床上是持续性的,抗心律失常治疗通常难治性的,有发生心动过速介导的心肌病的风险。导管消融在儿童中是有效和安全的;因此,应该根据个人选择及时指出。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.60
自引率
0.00%
发文量
73
审稿时长
20 weeks
期刊介绍: The Boletín Médico del Hospital Infantil de México is a bimonthly publication edited by the Hospital Infantil de México Federico Gómez. It receives unpublished manuscripts, in English or Spanish, relating to paediatrics in the following areas: biomedicine, clinical, public health, clinical epidemology, health education and clinical ethics. Articles can be original research articles, in-depth or systematic reviews, clinical cases, clinical-pathological cases, articles about public health, letters to the editor or editorials (by invitation).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信